These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Drug-induced toxic epidermal necrolysis. I. An overview. Lyell A Clin Dermatol; 1993; 11(4):491-2. PubMed ID: 8124637 [No Abstract] [Full Text] [Related]
16. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study. Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923 [TBL] [Abstract][Full Text] [Related]
17. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience. Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855 [TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis in Stevens--Johnson syndrome. Assaad D; From L; Ricciatti D; Shapero H Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383 [TBL] [Abstract][Full Text] [Related]
19. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722 [TBL] [Abstract][Full Text] [Related]
20. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]